Dexcel Pharma is a private, international, research based, healthcare group for the medical market. To date we employ over 900 people, with a presence in 19 countries worldwide, including subsidiaries in the US, UK and Germany.
As an international healthcare group, we are involved in all aspects of the pharmaceutical process from discovery through to research and development and then on to manufacturing and marketing the product.
We are totally committed to the discovery, development, manufacture and marketing of innovative drug formulations of successful established molecules.
Our products can be used for the treatment of gastroenterological, cardiovascular, and central nervous system diseases which are based on its 9 unique, modified-release, drug delivery technologies and 22 groups of patents.
Dexcel Pharma also develops and manufactures a broad range of controlled release and difficult to manufacture or develop generic products for worldwide distribution.